Update on Section 48(D) Tax Credit Program Activities

Cooley Alert
May 17, 2010

This serves as a reminder that guidelines for the Qualifying Therapeutic Discovery tax credit and grant provisions of the Health Care Reform Act (also called the Section 48(D) program) are scheduled for release this Friday, May 21. We encourage companies with potentially qualified programs to begin organizing their project information and consulting with their auditors or tax accountants to ensure timely preparation of their applications.

We are also prepared to assist you with review of applications and interpretation of the guidelines based on our extensive experience with life sciences clients and our experience with clean energy tax credit and grant programs.

We will continue to keep you informed about the most current guidance and interpretations as the impending regulations are published and discussed.

For reference, following are links to our recent Cooley Alerts on this Section 48(D) program:

We also would like to invite interested parties to consider an upcoming SVASE program "Life Science Gold Rush – The Healthcare Reform Bill has $1B in Grants & Tax Credits Available" to be held on May 20, 2010 at Cooley's Palo Alto office.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.